The latest news & stories from the Providence Research Network
-
How healthcare experiences impact preventative mammography: An interview with CORE's Monique Gill
In a new interview, Providence CORE researcher Monique Gill discusses CORE’s research on the links between healthcare experiences and engagement with mammography.
-
Bringing world-class procedures to remote patients
Learn how Providence is bringing top-tier research to its rural health programs so patients have access to lifesaving therapies – wherever they are.
-
Immunotherapies for GI and lung cancers evaluated in new studies
A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.
-
Genomic testing can improve outcomes for people with advanced cancer, study shows
Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.
-
Providence researchers contribute to 21 studies at SITC2023
SITC 2023 provides a glimpse into scientific advances and breakthroughs in cancer immunotherapy by researchers from around the world.
-
Understanding long COVID based on patient experiences
A new study examined patient experiences with long-COVID and identified four distinct groupings encompassing the wide-ranging experiences of long COVID patients.
-
Wish you could get rid of your COVID-19 symptoms sooner? Be part of a new study
The OakTree study is looking at a new COVID-19 drug to see if it can shorten the time you have symptoms. Learn more about participating.
-
Dr. Kelly Paulson wins first Jeff Ward Award
Swedish Edmonds Dr. Kelly Paulson wins the first-ever Jeff Ward Award for excellence in care.
-
The Search for New and Better Answers
Jaundice was the first symptom of what a CT scan would confirm was pancreatic cancer. A small tumor blocked one of Sharon Stefan’s bile ducts, causing the telltale symptom that, for many, doesn’t appe
-
Drawing on patient experiences, Providence study identifies four categories of long COVID and reveals importance of whole-person care
Providence study seeks to help practitioners better identify and care for patients by providing a more comprehensive understanding of how long COVID presents and the patient experience of this disease
-
New studies address unmet needs in treating triple-negative breast cancer
Two new studies available at Earle A. Chiles Research Institute, at division of Providence Cancer Institute of Oregon, to evaluate new treatments for triple-negative breast cancer.
-
A recent study found rising cancer rates among younger adults. What to know.
A recent study found an increased prevalence of cancer in people under 50. The study noted increases of endocrine, gastrointestinal and breast cancers in people between the ages of 30 and 39.
-
Dr. Urba receives award for his contributions to science and community
Providence Cancer Institute of Oregon, and research director, Earle A. Chiles Research Institute, Walter J. Urba, M.D., Ph.D., receives award for his contributions to science and community.
-
An antidote for addiction? Providence tests new meth treatment.
The METH-OD Study works to reverse the effects of Methamphetamine abuse. Read more about this innovative research and its successful outcomes for patients.
-
We’re winning the fight against prostate cancer
Providence Swedish is at the forefront of new technologies that decrease pain and shorten recovery time for prostate cancer patients.
-
New division director and deputy director of Hematology and Medical Oncology share a vision
Providence Cancer Institute of Oregon announces new division director and deputy director of Hematology and Medical Oncology.
-
New study aims to fill treatment gap for patients with endometrial cancer
For Gynecologic Cancer Awareness Month, Providence Cancer Institute highlights a clinical trial that evaluates the safety and effectiveness of a new oral treatment for grade 1 endometrial cancer.
-
A promising breakthrough in Leukemia treatments
A global study co-authored by Providence researchers shows significant promise for the treatment of Chronic lymphocytic leukemia/Small Lymphocytic Lymphoma
-
CORE study links a value-based payment model with increased outpatient healthcare use
A new study by Providence CORE linked a Value-based Payment Model with increased use of primary and specialty care among patients. Findings also highlight the importance of clinical staff buy-in.
-
Two trials evaluate new approaches to treating non-Hodgkin and follicular lymphomas
New trial open at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, is enrolling patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma.
-
Loading More...